Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

DocuSign Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Author: Avi Kapoor | September 05, 2024 12:25pm

DocuSign, Inc. (NASDAQ:DOCU) will release earnings results for its second quarter, after the closing bell on Thursday, Sept. 5.

Analysts expect the San Francisco, California-based company to report quarterly earnings at 80 cents per share, up from 72 cents per share in the year-ago period. DocuSign is projected to post revenue of $727.36 million, according to data from Benzinga Pro.

On June 25, Docusign announced new leadership appointments, naming Paula Hansen as President and Chief Revenue Officer and Sagnik Nandy as Chief Technology Officer.

DocuSign shares fell 0.9% to close at $57.42 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Piper Sandler analyst Rob Owens maintained a Neutral rating and cut the price target from $65 to $60 on June 7. This analyst has an accuracy rate of 81%.
  • B of A Securities analyst Brad Sills maintained a Neutral rating and slashed the price target from $72 to $60 on June 7. This analyst has an accuracy rate of 74%.
  • Baird analyst William Power maintained a Neutral rating and cut the price target from $65 to $55 on June 7. This analyst has an accuracy rate of 85%.
  • Citigroup analyst Tyler Radke maintained a Buy rating and slashed the price target from $93 to $86 on June 5. This analyst has an accuracy rate of 68%.
  • UBS analyst Karl Keirstead upgraded the stock from Sell to Neutral and raised the price target from $48 to $62 on April 12. This analyst has an accuracy rate of 74%.

Considering buying DOCU stock? Here’s what analysts think:

Read This Next:

Posted In: DOCU

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist